Immunosuppression appears to reduce mortality among people with systemic sclerosis with pulmonary arterial hypertension but ...

The Chronic Thromboembolic Pulmonary Hypertension (CTEPH) program at Baylor St. Luke’s Medical Center is one of a handful of specialized programs in the country offering expert multidisciplinary care ...

At this year’s Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), a day-long CTEPH conference—co-sponsored by ISHLT and the International ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy ...